This year we lost a pioneer in the search for better treatments for persons with schizophrenia. Over three decades, Gerard Hogarty, M.S.W., professor of psychiatry at the University of Pittsburgh, conducted a research crusade to enhance patients' lives. His creativity was unique, his science impeccable, and his enthusiasm infectious. His particular legacy was the invention and application of novel psychosocial treatments. His seminal studies provided proof that combining specific forms of psychosocial treatments with pharmacotherapy leads to better outcomes than monotherapies. Most incredibly, he did this repeatedly, like no one before or since.